Biofil Chemicals & Pharmaceuticals Ltd
Intimation To Members - Availability Of Dispute Resolution Mechanism At Stock Exchanges Against Comp
12:30 PM, 22nd Feb 2023
In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations 2015 as amended we wish to state that the Company was informed by its Registrar and Share Transfer Agent i.e. Ankit Consultancy Private Limited that they have duly completed the process of sending intimation via email on 10th February 2023 to the Members of the Biofil Chemicals And Pharmaceuticals Limited pertaining to SEBI Circular No. SEBI/HO/OIAE/2023/03391dated January 27 2023 read together with SEBI /HO/ MIRSD/MIRSD_RTAMB/P/CIR/2022/76 dated May 30 2022 regarding availability of Dispute Resolution Mechanism at Stock Exchanges against Company/Registrar to an Issue and Share Transfer Agents (RTA). Summary of the aforesaid communications is being made available on our website at: www.biofilgroup.net under Investors Section.